FindMyRecallSubscribe
Class I: serious health riskTerminated

AuroMedics Pharma Polymyxin B for Injection Recall

Polymyxin B for Injection USP, 500,000 Units per Vial, 10 mL vials, packaged in 10 vial…

AuroMedics Pharma LLC · East Windsor, NJ

Risk level
Class I
Reported by FDA
Feb 16, 2022
Recall ID
D-0556-2022
Check your lot numberHow we source this data

Summary

AuroMedics Pharma recalled Polymyxin B for Injection starting Jan 26, 2022. The FDA classified it as Class I (serious health risk) and published enforcement report D-0556-2022 on Feb 16, 2022. Reason: Presence of Particulate Matter; product complaint of hair discovered in a vial within the lot. Status: Terminated.

Why it was recalled

Presence of Particulate Matter; product complaint of hair discovered in a vial within the lot

Product description

Polymyxin B for Injection USP, 500,000 Units per Vial, 10 mL vials, packaged in 10 vials per carton, Sterile, Rx Only, Distributed by: AuroMedics Pharma LLC, E. Windsor, NJ 08520, NDC 55150-234-10

Lot numbers, UPCs & expiration codes

Lot CPB200013, exp 9/2022

Where it was sold

Nationwide in the US

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0556-2022
Classification
Class I
Status
Terminated
Recall initiated
Jan 26, 2022
FDA report date
Feb 16, 2022
Quantity
35,520 vials
Recall type
Voluntary: Firm initiated
Recalling firm
AuroMedics Pharma LLC

Original FDA data

Every field from FDA enforcement report D-0556-2022, exactly as published.

Show all FDA fields
City
East Windsor
State
NJ
Status
Terminated
Country
United States
Event ID
89457
Address
279 Princeton Hightstown Rd
Code information
Lot CPB200013, exp 9/2022
Postal code
08520-1401
Report date
Feb 16, 2022
Product type
Drugs
Recall number
D-0556-2022
Classification
Class I
Recalling firm
AuroMedics Pharma LLC
Product quantity
35,520 vials
Termination date
Aug 20, 2024
Reason for recall
Presence of Particulate Matter; product complaint of hair discovered in a vial within the lot
Voluntary / mandated
Voluntary: Firm initiated
Product description
Polymyxin B for Injection USP, 500,000 Units per Vial, 10 mL vials, packaged in 10 vials per carton, Sterile, Rx Only, Distributed by: AuroMedics Pharma LLC, E. Windsor, NJ 08520, NDC 55150-234-10
Distribution pattern
Nationwide in the US
Recall initiation date
Jan 26, 2022
Initial firm notification
Letter
Center classification date
Feb 10, 2022

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0556-2022, published Feb 16, 2022. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls